Logo image of BRN

BARNWELL INDUSTRIES INC (BRN) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:BRN - US0682211000 - Common Stock

1.14 USD
-0.03 (-2.56%)
Last: 1/20/2026, 12:16:43 PM
Fundamental Rating

2

Overall BRN gets a fundamental rating of 2 out of 10. We evaluated BRN against 207 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of BRN is average, but there are quite some concerns on its profitability. BRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year BRN has reported negative net income.
  • BRN had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BRN reported negative net income in multiple years.
  • Of the past 5 years BRN 4 years had a positive operating cash flow.
BRN Yearly Net Income VS EBIT VS OCF VS FCFBRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

1.2 Ratios

  • BRN has a Return On Assets of -34.13%. This is amonst the worse of the industry: BRN underperforms 92.75% of its industry peers.
  • With a Return On Equity value of -101.36%, BRN is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -34.13%
ROE -101.36%
ROIC N/A
ROA(3y)-18.33%
ROA(5y)-2.92%
ROE(3y)-49.72%
ROE(5y)-10.91%
ROIC(3y)N/A
ROIC(5y)N/A
BRN Yearly ROA, ROE, ROICBRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • BRN has a Gross Margin (31.98%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of BRN has grown nicely.
  • BRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.71%
GM growth 5Y1.92%
BRN Yearly Profit, Operating, Gross MarginsBRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

  • BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BRN has been increased compared to 1 year ago.
  • BRN has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRN Yearly Shares OutstandingBRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BRN Yearly Total Debt VS Total AssetsBRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -0.11, we must say that BRN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.11, BRN is not doing good in the industry: 67.15% of the companies in the same industry are doing better.
  • BRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.11
ROIC/WACCN/A
WACC8.88%
BRN Yearly LT Debt VS Equity VS FCFBRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

2.3 Liquidity

  • BRN has a Current Ratio of 1.11. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.11, BRN perfoms like the industry average, outperforming 48.79% of the companies in the same industry.
  • BRN has a Quick Ratio of 1.11. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.11, BRN is in line with its industry, outperforming 57.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
BRN Yearly Current Assets VS Current LiabilitesBRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

  • The earnings per share for BRN have decreased strongly by -27.15% in the last year.
  • The Revenue for BRN has decreased by -32.91% in the past year. This is quite bad
  • The Revenue has been decreasing by -5.34% on average over the past years.
EPS 1Y (TTM)-27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.43%
Revenue 1Y (TTM)-32.91%
Revenue growth 3Y-20.49%
Revenue growth 5Y-5.34%
Sales Q2Q%-29.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRN Yearly Revenue VS EstimatesBRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRN Price Earnings VS Forward Price EarningsBRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRN Per share dataBRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

  • BRN has a Yearly Dividend Yield of 2.31%.
  • Compared to an average industry Dividend Yield of 3.75, BRN has a dividend in line with its industry peers.
  • BRN's Dividend Yield is a higher than the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

  • BRN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BRN Yearly Dividends per shareBRN Yearly Dividends per shareYearly Dividends per share 2022 2023 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BRN Yearly Income VS Free CF VS DividendBRN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

More info and screens

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (1/20/2026, 12:16:43 PM)

1.14

-0.03 (-2.56%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-15
Earnings (Next)02-12
Inst Owners8.79%
Inst Owner Change0%
Ins Owners43.65%
Ins Owner Change10.48%
Market Cap11.48M
Revenue(TTM)14.24M
Net Income(TTM)-7.10M
Analysts0
Price TargetN/A
Short Float %0.86%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 1.64
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS1.41
BVpS0.7
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.13%
ROE -101.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.98%
FCFM N/A
ROA(3y)-18.33%
ROA(5y)-2.92%
ROE(3y)-49.72%
ROE(5y)-10.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.71%
GM growth 5Y1.92%
F-Score2
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.71%
Cap/Sales 21.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z -0.11
F-Score2
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)142.59%
Cap/Depr(5y)199.3%
Cap/Sales(3y)28.54%
Cap/Sales(5y)26.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.91%
Revenue growth 3Y-20.49%
Revenue growth 5Y-5.34%
Sales Q2Q%-29.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-517.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.66%
OCF growth 3YN/A
OCF growth 5YN/A

BARNWELL INDUSTRIES INC / BRN FAQ

What is the ChartMill fundamental rating of BARNWELL INDUSTRIES INC (BRN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BRN.


What is the valuation status of BARNWELL INDUSTRIES INC (BRN) stock?

ChartMill assigns a valuation rating of 0 / 10 to BARNWELL INDUSTRIES INC (BRN). This can be considered as Overvalued.


Can you provide the profitability details for BARNWELL INDUSTRIES INC?

BARNWELL INDUSTRIES INC (BRN) has a profitability rating of 2 / 10.